Cannabis compounds CBG and THC tested for pain and hunger boost

NCT ID NCT04859296

Ongoing Symptom relief Sponsor: University of California, Los Angeles Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early study tests whether vaporized cannabigerol (CBG) and THC can help with pain and appetite. Twenty occasional cannabis users will receive different doses of CBG and THC, alone or together, and report their pain tolerance, hunger, and any side effects. The goal is to see if these compounds are safe and effective for these symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cannabigerol (CBG) and Delta-9-tetrahydrocannabinol (THC) vaporized
What this could lead to: If it works, this could point toward a treatment for pain and appetite loss using cannabis compounds.
What could go wrong: This is a very small, early-phase study with only 20 participants. Results may not apply to everyone, and the compounds may cause intoxication or abuse potential.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABUSE, DRUG are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia Anorexia Pain substance abuse substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ABUSE, DRUG APPETITE LOSS PAIN

Contacts and locations

Locations

University of California, Los Angeles

Los Angeles, California, 90095, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.